Track the 동국제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 동국제약 has published 21 public disclosures. The latest transaction was reported on 26 May 2026 (Sale). Among the most active insiders: 브이아이피자산운용. The full history is free.
21
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
14 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.